| 标题 |
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of the rheumatic diseases 作者:Liu J; Jiang Y; Zhang S; Liu S; Su J; et al 出版日期:2025/02/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)